228 related articles for article (PubMed ID: 10789229)
1. [Surgical treatment of stage IIIA non-small-cell lung cancer].
Porkhanov VA; Mova VS; Kononenko VB; Bodnia VN; Poliakov IS
Vopr Onkol; 2000; 46(1):74-6. PubMed ID: 10789229
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
3. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
5. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
6. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.
Okada M; Sakamoto T; Yuki T; Mimura T; Miyoshi K; Tsubota N
Ann Thorac Surg; 2006 Mar; 81(3):1028-32. PubMed ID: 16488715
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
11. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Gong M
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
[TBL] [Abstract][Full Text] [Related]
14. [Long-term results after resection of IIIA-N2 non-small cell lung cancer and complementary mediastinal irradiation].
Pepliński J; Kowalewski J; Skokowski J; Dancewicz M
Pol Merkur Lekarski; 2004 Nov; 17(101):431-4. PubMed ID: 15754625
[TBL] [Abstract][Full Text] [Related]
15. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
16. [Effect of postoperative thoracic radiotherapy on the survival of patients with stage IIIA (N2 disease) non-small-cell lung cancer].
Chabowski M; Orłowski TM
Pol Merkur Lekarski; 2004 Oct; 17(100):345-8. PubMed ID: 15690698
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer.
Nakanishi R; Osaki T; Nakanishi K; Yoshino I; Yoshimatsu T; Watanabe H; Nakata H; Yasumoto K
Ann Thorac Surg; 1997 Aug; 64(2):342-8. PubMed ID: 9262572
[TBL] [Abstract][Full Text] [Related]
18. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
Doddoli C; Aragon A; Barlesi F; Chetaille B; Robitail S; Giudicelli R; Fuentes P; Thomas P
Eur J Cardiothorac Surg; 2005 Apr; 27(4):680-5. PubMed ID: 15784374
[TBL] [Abstract][Full Text] [Related]
19. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]